Loading...
Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model
BACKGROUND: Topical administration of PR022, 0.05% hypochlorous acid (HOCl) in gel has been demonstrated to be beneficial in a chronic murine atopic dermatitis model. In a follow up study we tested a higher concentration (0.1%) of PR022 HOCl gel in comparison to the Janus kinase inhibitor tofacitini...
Na minha lista:
| Udgivet i: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6029395/ https://ncbi.nlm.nih.gov/pubmed/29970189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-018-0232-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|